Cargando…
Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS)
BACKGROUND: Dehydroepiandrosterone (DHEA) has been reported to improve pregnancy chances in women with diminished ovarian reserve (DOR), and to reduce miscarriage rates by 50-80%. Such an effect is mathematically inconceivable without beneficial effects on embryo ploidy. This study, therefore, asses...
Autores principales: | Gleicher, Norbert, Weghofer, Andrea, Barad, David H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992540/ https://www.ncbi.nlm.nih.gov/pubmed/21067609 http://dx.doi.org/10.1186/1477-7827-8-140 |
Ejemplares similares
-
Accuracy of preimplantation genetic screening (PGS) is compromised by degree of mosaicism of human embryos
por: Gleicher, Norbert, et al.
Publicado: (2016) -
Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR)
por: Gleicher, Norbert, et al.
Publicado: (2011) -
Preimplantation genetic screening (PGS) still in search of a clinical application: a systematic review
por: Gleicher, Norbert, et al.
Publicado: (2014) -
Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study
por: Gleicher, Norbert, et al.
Publicado: (2009) -
Is the hypothesis of preimplantation genetic screening (PGS) still supportable? A review
por: Gleicher, Norbert, et al.
Publicado: (2017)